#323: Why Does Drug Loss Occur? Challenges to be Addressed for Patients, and Japan's Contribution to Globalized Drug Development

#323: Why Does Drug Loss Occur? Challenges to be Addressed for Patients, and Japan's Contribution to Globalized Drug Development

Wednesday, June 18, 2025 10:30 AM to 11:30 AM · 1 hr. (America/New_York)
151B
07: ProjectManagement-StrategicPlanning

Information

This forum will address need for a global development strategy aimed at enhancing patient access to new drugs and maximizing business opportunities in Japan. The panelists will consist of members from pharma industry associations, agency and academia
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Global PerspectivesRare Disease
Learning Objectives
Discuss maximizing value of innovative products for the global market including Japan; Apply learnings to clinical development strategy to expand target patients and market effectively; Describe need to enhance access to innovative drugs for children and patients with rare diseases; Discuss influencing regulators, industry, and trial sites to improve the local environment and reduce burdens in global simultaneous development.

Log in

See all the content and easy-to-use features by logging in or registering!